Market icon

RFK 将停止对哪些疫苗的推荐?

Market icon

RFK 将停止对哪些疫苗的推荐?

$1,399,277 交易量

2025-12-31
Polymarket

$1,399,277 交易量

Polymarket

脊髓灰质炎

$22,600 交易量

COVID-19

$602,048 交易量

人乳头瘤病毒

$316,492 交易量

流感

$28,349 交易量

乙型肝炎

$166,216 交易量

麻疹、腮腺炎和风疹

$263,573 交易量

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution. The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.

The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
交易量
$1,399,277
结束日期
2025-12-31
市场开放时间
Feb 21, 2025, 7:10 PM ET
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution. The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

已提议结果: 否

无争议

最终结果: 否

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution. The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”.

A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution.

The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).
交易量
$1,399,277
结束日期
2025-12-31
市场开放时间
Feb 21, 2025, 7:10 PM ET
This market will resolve to "Yes" if the CDC has completely ended its recommendation for the listed vaccine, meaning it no longer recommends it for any category of individuals by December 31, 2025, 11:59 PM ET. Otherwise, this market will resolve to “No”. A reduction in the scope of recommended recipients, or the removal of a recommendation for a specific type of vaccine for the listed disease (e.g. CDC removal of the recommendation for the live oral polio vaccine in 2022) without fully eliminating the recommendation will not be sufficient for a "Yes" resolution. The resolution source will be official CDC announcements and guidance published on the CDC website (see: https://www.cdc.gov/acip-recs/hcp/vaccine-specific/).

已提议结果: 否

无争议

最终结果: 否

警惕外部链接哦。

常见问题

"RFK 将停止对哪些疫苗的推荐?"是 Polymarket 上一个拥有 6 个可能结果的预测市场,交易者根据自己的判断买卖份额。当前领先结果为"脊髓灰质炎",概率为 0%,其次是"COVID-19",概率为 0%。价格反映社区的实时概率。例如,价格为 0¢ 的份额意味着市场集体认为该结果的概率为 0%。这些赔率会随着交易者的反应而不断变化。正确结果的份额在市场结算时可兑换为每份 $1。

截至目前,"RFK 将停止对哪些疫苗的推荐?"已产生 $1.4 million 的总交易量(自Feb 22, 2025市场上线以来)。这一活跃度反映了 Polymarket 社区的高度参与,并确保当前赔率由广泛的市场参与者共同形成。你可以直接在本页追踪实时价格变动并交易任何结果。

要在"RFK 将停止对哪些疫苗的推荐?"上交易,浏览本页上列出的 6 个可用结果。每个结果显示一个代表市场隐含概率的当前价格。要建仓,选择你认为最可能的结果,选择"是"支持或"否"反对,输入金额并点击"交易"。如果你选择的结果在市场结算时正确,你的"是"份额每份支付 $1。如果不正确,支付 $0。你也可以在结算前随时卖出份额。

这是一个非常开放的市场。"RFK 将停止对哪些疫苗的推荐?"的当前领先者是"脊髓灰质炎",仅有 0%,"COVID-19"紧随其后为 0%。由于没有任何结果占据明显优势,交易者认为这高度不确定,可能带来独特的交易机会。这些赔率实时更新,请将本页加入书签。

"RFK 将停止对哪些疫苗的推荐?"的结算规则明确定义了每个结果被宣布为获胜者所需满足的条件——包括用于确定结果的官方数据来源。你可以在本页评论上方的"规则"部分查看完整的结算标准。我们建议在交易前仔细阅读规则,因为它们规定了精确的条件、特殊情况和数据来源。